| LUARC LA JOLLA PHARMACEUTICAL COMPANY
1144361 19 Jun 2002 | on 14 Dec 2005 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for prevention and/or treatment of antibody-mediated diseases, namely, systemic lupus erythematosus, RH hemolytic disease of the newborn, antiphospholipid antibody syndrome, Grave's disease, myasthenia gravis, Hashimoto's thyroiditis, pemphigus, autoimmune hemolytic anemia, autoimmune thrombocytopenia purpura, antibody mediated infertility , Sjogre's syndrome, mixed connective tissue disease, glomerulonephritis and Goodpasture's syndrome. | | 
